1.
Vestn Otorinolaringol
; (2): 42-5, 1996.
Article
in Russian
| MEDLINE
| ID: mdl-8711846
ABSTRACT
Clinical and microbiological findings led the authors to the conclusion that antibacterial drugs rovamycin and amox-clav are active against ENT infection and inflammation. The trial included 69 and 42 patients given rovamycin and amox-clav, respectively.
Subject(s)
Bacterial Infections/drug therapy , Drug Therapy, Combination/therapeutic use , Otorhinolaryngologic Diseases/drug therapy , Spiramycin/therapeutic use , Adolescent , Adult , Aged , Amoxicillin/administration & dosage , Amoxicillin/therapeutic use , Amoxicillin-Potassium Clavulanate Combination , Bacteria/isolation & purification , Clavulanic Acids/administration & dosage , Clavulanic Acids/therapeutic use , Drug Therapy, Combination/administration & dosage , Female , Humans , Inflammation , Male , Middle Aged , Otorhinolaryngologic Diseases/microbiology , Spiramycin/administration & dosage , Time Factors
2.
Vestn Otorinolaringol
; (5): 44-7, 1995.
Article
in Russian
| MEDLINE
| ID: mdl-7502455